Fluorescent nanoparticle-mediated semiquantitative MYC protein expression analysis in morphologically diffuse large...

Area of Science:

• Hematology
• Oncology
• Biotechnology

Background:

• The World Health Organization (WHO) classification identifies high-grade B-cell lymphoma with specific gene rearrangements, necessitating fluorescence in situ hybridization (FISH) screening.
• MYC expression's prognostic significance in diffuse large B-cell lymphoma (DLBCL) is recognized, but interobserver variability in immunohistochemistry (IHC) and inconsistent cut-off values hinder its clinical application.
• Accurate MYC protein evaluation is crucial for DLBCL prognosis, independent of genetic rearrangements.

Purpose of the Study:

• To evaluate MYC protein expression in de novo DLBCL using a high-sensitivity phosphor-integrated dot (PID)-mediated IHC technique.
• To compare the prognostic value of PID-mediated MYC detection with the conventional diaminobenzidine (DAB) system.
• To determine if precise MYC protein evaluation clarifies prognostic values in DLBCL.

Main Methods:

• A cohort of 50 de novo DLBCL cases was analyzed using a semiquantitative IHC technique with PID.
• MYC expression was also assessed using the conventional DAB developing system for comparison.
• Overall survival was analyzed in relation to MYC expression levels determined by both methods.

Main Results:

• High MYC expression detected by the PID-mediated system was significantly associated with poor overall survival in DLBCL patients.
• The conventional DAB system failed to demonstrate any prognostic value for MYC protein expression, even when considering varying intensity and cut-off values.
• PID-mediated MYC evaluation provided a clear prognostic indicator, unlike the DAB method.

Conclusions:

• The PID-mediated IHC technique offers a more precise and reliable method for evaluating MYC protein expression in DLBCL.
• Accurate MYC protein assessment using PID can clarify prognostic implications in DLBCL, irrespective of MYC rearrangement status.
• This advanced technique holds potential for improving risk stratification and treatment decisions in DLBCL management.